rivaroxaban우선순위 중간ICSR 검토리뷰
LITERATURE DETAIL · PMID 42605337
Cutting-Edge Cardiology: Individualizing Antiplatelet Therapy for Optimal Acute Coronary Syndrome Outcomes.
Cutting-Edge Cardiology: Individualizing Antiplatelet Therapy for Optimal Acute Coronary Syndrome Outcomes.
- 저자
- Gilbert Abounader, Sarah Bejjani, Said M Chaaban, Sobhi Dada, Robert Fakhoury, Malek Hamade
- 저널
- Cureus
- 공개일
- 2026 Jul
- 연구 유형
- 리뷰
- DOI
- 10.7759/cureus.112849
문헌 요약
Dual antiplatelet therapy (DAPT), consisting of aspirin and a P2Y12 inhibitor, is fundamental after percutaneous coronary intervention (PCI) in acute coronary syndromes (ACSs). Recent evidence supports moving from a uniform to an individualized approach, tailoring therapy duration and intensity to patient-specific ischemic and bleeding risks. A targeted l…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.